Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 5.58373296 |
2 | ATP synthesis coupled proton transport (GO:0015986) | 4.82000076 |
3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.82000076 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.47341404 |
5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.35059866 |
6 | ribosomal small subunit assembly (GO:0000028) | 4.29037858 |
7 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.07204266 |
8 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.07204266 |
9 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.68232350 |
10 | proteasome assembly (GO:0043248) | 3.63848888 |
11 | protein complex biogenesis (GO:0070271) | 3.62158732 |
12 | cytidine metabolic process (GO:0046087) | 3.61877512 |
13 | cytidine catabolic process (GO:0006216) | 3.61877512 |
14 | cytidine deamination (GO:0009972) | 3.61877512 |
15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57500704 |
16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.43571770 |
17 | NADH dehydrogenase complex assembly (GO:0010257) | 3.43571770 |
18 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.43571770 |
19 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.41212510 |
20 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.34511589 |
21 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.32900043 |
22 | platelet dense granule organization (GO:0060155) | 3.28756624 |
23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.27797308 |
24 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.25098547 |
25 | electron transport chain (GO:0022900) | 3.21885046 |
26 | mannosylation (GO:0097502) | 3.21208047 |
27 | respiratory electron transport chain (GO:0022904) | 3.20748527 |
28 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.18437886 |
29 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.17112298 |
30 | GTP biosynthetic process (GO:0006183) | 3.16300472 |
31 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.09178871 |
32 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.09178871 |
33 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.09178871 |
34 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.08200123 |
35 | ribosomal large subunit biogenesis (GO:0042273) | 3.06867197 |
36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.06036215 |
37 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.06036215 |
38 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.05924757 |
39 | sequestering of actin monomers (GO:0042989) | 3.03198406 |
40 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01100870 |
41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.99848431 |
42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.95715396 |
43 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.95715396 |
44 | pseudouridine synthesis (GO:0001522) | 2.95247057 |
45 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93636181 |
46 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.92460043 |
47 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.92008923 |
48 | metallo-sulfur cluster assembly (GO:0031163) | 2.91694487 |
49 | iron-sulfur cluster assembly (GO:0016226) | 2.91694487 |
50 | behavioral response to nicotine (GO:0035095) | 2.90148270 |
51 | adenosine metabolic process (GO:0046085) | 2.89267125 |
52 | respiratory chain complex IV assembly (GO:0008535) | 2.88629910 |
53 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.87946544 |
54 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.86590760 |
55 | protein neddylation (GO:0045116) | 2.86511520 |
56 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.85878492 |
57 | negative regulation of ligase activity (GO:0051352) | 2.85878492 |
58 | GPI anchor metabolic process (GO:0006505) | 2.85226967 |
59 | cullin deneddylation (GO:0010388) | 2.82933733 |
60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81393478 |
61 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.81379059 |
62 | positive regulation of prostaglandin secretion (GO:0032308) | 2.81332058 |
63 | ATP biosynthetic process (GO:0006754) | 2.78992672 |
64 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.78287867 |
65 | rRNA modification (GO:0000154) | 2.77112372 |
66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77093980 |
67 | cellular response to interleukin-15 (GO:0071350) | 2.77032182 |
68 | base-excision repair, AP site formation (GO:0006285) | 2.75312730 |
69 | response to pheromone (GO:0019236) | 2.75161185 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.74206334 |
71 | protein deneddylation (GO:0000338) | 2.73619199 |
72 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.72418104 |
73 | GPI anchor biosynthetic process (GO:0006506) | 2.71901402 |
74 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.71816147 |
75 | termination of RNA polymerase III transcription (GO:0006386) | 2.69752038 |
76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.69752038 |
77 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.69682628 |
78 | xenobiotic catabolic process (GO:0042178) | 2.67995815 |
79 | proton transport (GO:0015992) | 2.67383185 |
80 | hydrogen ion transmembrane transport (GO:1902600) | 2.67231998 |
81 | positive regulation of defense response to virus by host (GO:0002230) | 2.65936247 |
82 | rRNA catabolic process (GO:0016075) | 2.65283920 |
83 | cytochrome complex assembly (GO:0017004) | 2.64732374 |
84 | tRNA processing (GO:0008033) | 2.61086430 |
85 | hydrogen transport (GO:0006818) | 2.60681998 |
86 | UTP metabolic process (GO:0046051) | 2.60629380 |
87 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.60403834 |
88 | negative T cell selection (GO:0043383) | 2.59319327 |
89 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.58649596 |
90 | detection of light stimulus involved in visual perception (GO:0050908) | 2.58641392 |
91 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.58641392 |
92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.57797477 |
93 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.57775219 |
94 | translational elongation (GO:0006414) | 2.56706555 |
95 | UTP biosynthetic process (GO:0006228) | 2.56684722 |
96 | maturation of 5.8S rRNA (GO:0000460) | 2.56661876 |
97 | viral transcription (GO:0019083) | 2.55085812 |
98 | translation (GO:0006412) | 2.54815743 |
99 | regulation of chronic inflammatory response (GO:0002676) | 2.53745199 |
100 | cotranslational protein targeting to membrane (GO:0006613) | 2.53701056 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.21657933 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.18260666 |
3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.90206834 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.89834576 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.45864210 |
6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.44933908 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.13960363 |
8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.07225805 |
9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.95769708 |
10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81646350 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.81035987 |
12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.75727800 |
13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.72382374 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.58169334 |
15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.38328404 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.37742053 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.17469633 |
18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.16874214 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06816987 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00867528 |
21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99780610 |
22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.99632623 |
23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.95756277 |
24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.94135349 |
25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90818862 |
26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89695819 |
27 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.86419015 |
28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76200847 |
29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63768661 |
30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53452132 |
31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50455861 |
32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48243081 |
33 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.43037417 |
34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42713354 |
35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42429849 |
36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41910010 |
37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39959372 |
38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39678395 |
39 | AR_20517297_ChIP-Seq_VCAP_Human | 1.38135199 |
40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.35750927 |
41 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.35668039 |
42 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.35668039 |
43 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.32449332 |
44 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.30526796 |
45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.30317114 |
46 | MYB_26560356_Chip-Seq_TH2_Human | 1.30251931 |
47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29052949 |
48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27354088 |
49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27057902 |
50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25295604 |
51 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.24043272 |
52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22269226 |
53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21472921 |
54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21209422 |
55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19774092 |
56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19440428 |
57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17568078 |
58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16862830 |
59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16401075 |
60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16292156 |
61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15976441 |
62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15655268 |
63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13086837 |
64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12822467 |
65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12608334 |
66 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10490582 |
67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10490582 |
68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.10436916 |
69 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08927440 |
70 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08498689 |
71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06413500 |
72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05789501 |
73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05378628 |
74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05036746 |
75 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04736378 |
76 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04635412 |
77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03546951 |
78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03366441 |
79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02555337 |
80 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.01919215 |
81 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01089137 |
82 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.00743243 |
83 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00676235 |
84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99527421 |
85 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.99272515 |
86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99227436 |
87 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99015608 |
88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98340769 |
89 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98052231 |
90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96049557 |
91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95668344 |
92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95283330 |
93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94789845 |
94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94643549 |
95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94643549 |
96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93432852 |
97 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93194355 |
98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93134310 |
99 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93058694 |
100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92993113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.59656721 |
2 | MP0002163_abnormal_gland_morphology | 3.24802842 |
3 | MP0002102_abnormal_ear_morphology | 2.82139191 |
4 | MP0001835_abnormal_antigen_presentation | 2.74423989 |
5 | MP0008877_abnormal_DNA_methylation | 2.55865926 |
6 | MP0005645_abnormal_hypothalamus_physiol | 2.44520823 |
7 | MP0006072_abnormal_retinal_apoptosis | 2.37375146 |
8 | MP0005379_endocrine/exocrine_gland_phen | 2.32409443 |
9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.29979408 |
10 | MP0004147_increased_porphyrin_level | 2.22118058 |
11 | MP0008872_abnormal_physiological_respon | 2.12464502 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.08222566 |
13 | MP0009785_altered_susceptibility_to | 2.04485360 |
14 | MP0002166_altered_tumor_susceptibility | 1.96811224 |
15 | MP0005084_abnormal_gallbladder_morpholo | 1.92370775 |
16 | MP0002148_abnormal_hypersensitivity_rea | 1.89359604 |
17 | MP0003763_abnormal_thymus_physiology | 1.86797368 |
18 | MP0002876_abnormal_thyroid_physiology | 1.79699863 |
19 | MP0001800_abnormal_humoral_immune | 1.78901901 |
20 | MP0005551_abnormal_eye_electrophysiolog | 1.78316973 |
21 | MP0002006_tumorigenesis | 1.77668643 |
22 | MP0003866_abnormal_defecation | 1.76316268 |
23 | MP0002736_abnormal_nociception_after | 1.74886843 |
24 | MP0003195_calcinosis | 1.71124342 |
25 | MP0005646_abnormal_pituitary_gland | 1.65782927 |
26 | MP0005000_abnormal_immune_tolerance | 1.65127034 |
27 | MP0000685_abnormal_immune_system | 1.60610438 |
28 | MP0003786_premature_aging | 1.56891213 |
29 | MP0005360_urolithiasis | 1.53434117 |
30 | MP0001968_abnormal_touch/_nociception | 1.52483074 |
31 | MP0003011_delayed_dark_adaptation | 1.50159375 |
32 | MP0002723_abnormal_immune_serum | 1.48414203 |
33 | MP0003724_increased_susceptibility_to | 1.46223857 |
34 | MP0008058_abnormal_DNA_repair | 1.45359600 |
35 | MP0003646_muscle_fatigue | 1.44483402 |
36 | MP0005075_abnormal_melanosome_morpholog | 1.43174739 |
37 | MP0005253_abnormal_eye_physiology | 1.42394192 |
38 | MP0004885_abnormal_endolymph | 1.42174065 |
39 | MP0001919_abnormal_reproductive_system | 1.41684567 |
40 | MP0002837_dystrophic_cardiac_calcinosis | 1.41347385 |
41 | MP0002420_abnormal_adaptive_immunity | 1.39362130 |
42 | MP0002277_abnormal_respiratory_mucosa | 1.39284577 |
43 | MP0001819_abnormal_immune_cell | 1.38508695 |
44 | MP0005389_reproductive_system_phenotype | 1.37537799 |
45 | MP0001873_stomach_inflammation | 1.36942889 |
46 | MP0002452_abnormal_antigen_presenting | 1.35061435 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.31223076 |
48 | MP0000372_irregular_coat_pigmentation | 1.26627975 |
49 | MP0001905_abnormal_dopamine_level | 1.26611059 |
50 | MP0004142_abnormal_muscle_tone | 1.26588583 |
51 | MP0006292_abnormal_olfactory_placode | 1.25188664 |
52 | MP0005387_immune_system_phenotype | 1.25123457 |
53 | MP0001790_abnormal_immune_system | 1.25123457 |
54 | MP0005410_abnormal_fertilization | 1.23826433 |
55 | MP0005377_hearing/vestibular/ear_phenot | 1.22646492 |
56 | MP0003878_abnormal_ear_physiology | 1.22646492 |
57 | MP0006035_abnormal_mitochondrial_morpho | 1.21797932 |
58 | MP0001986_abnormal_taste_sensitivity | 1.20060701 |
59 | MP0009764_decreased_sensitivity_to | 1.19804096 |
60 | MP0003806_abnormal_nucleotide_metabolis | 1.18465133 |
61 | MP0001764_abnormal_homeostasis | 1.08857156 |
62 | MP0003252_abnormal_bile_duct | 1.07996242 |
63 | MP0004145_abnormal_muscle_electrophysio | 1.07336240 |
64 | MP0005025_abnormal_response_to | 1.07045065 |
65 | MP0009379_abnormal_foot_pigmentation | 1.04592714 |
66 | MP0008995_early_reproductive_senescence | 1.02381689 |
67 | MP0000613_abnormal_salivary_gland | 1.01033316 |
68 | MP0000689_abnormal_spleen_morphology | 1.00850063 |
69 | MP0003718_maternal_effect | 1.00510764 |
70 | MP0000716_abnormal_immune_system | 1.00039255 |
71 | MP0001845_abnormal_inflammatory_respons | 0.99607879 |
72 | MP0006036_abnormal_mitochondrial_physio | 0.97214106 |
73 | MP0003436_decreased_susceptibility_to | 0.97148131 |
74 | MP0001529_abnormal_vocalization | 0.95433290 |
75 | MP0002160_abnormal_reproductive_system | 0.95058460 |
76 | MP0003880_abnormal_central_pattern | 0.94645276 |
77 | MP0002398_abnormal_bone_marrow | 0.92566123 |
78 | MP0005085_abnormal_gallbladder_physiolo | 0.92190834 |
79 | MP0005167_abnormal_blood-brain_barrier | 0.90967675 |
80 | MP0005636_abnormal_mineral_homeostasis | 0.90636453 |
81 | MP0005365_abnormal_bile_salt | 0.90556394 |
82 | MP0001501_abnormal_sleep_pattern | 0.89412483 |
83 | MP0006276_abnormal_autonomic_nervous | 0.87302608 |
84 | MP0001119_abnormal_female_reproductive | 0.85815962 |
85 | MP0005332_abnormal_amino_acid | 0.85783375 |
86 | MP0002938_white_spotting | 0.85418557 |
87 | MP0002722_abnormal_immune_system | 0.84444213 |
88 | MP0000647_abnormal_sebaceous_gland | 0.84285073 |
89 | MP0010155_abnormal_intestine_physiology | 0.84182454 |
90 | MP0002405_respiratory_system_inflammati | 0.81892905 |
91 | MP0002272_abnormal_nervous_system | 0.81540302 |
92 | MP0002693_abnormal_pancreas_physiology | 0.80625716 |
93 | MP0008469_abnormal_protein_level | 0.79840526 |
94 | MP0002638_abnormal_pupillary_reflex | 0.78759528 |
95 | MP0003186_abnormal_redox_activity | 0.77192427 |
96 | MP0000703_abnormal_thymus_morphology | 0.76644217 |
97 | MP0001765_abnormal_ion_homeostasis | 0.75803427 |
98 | MP0002429_abnormal_blood_cell | 0.75117055 |
99 | MP0000465_gastrointestinal_hemorrhage | 0.74387528 |
100 | MP0001929_abnormal_gametogenesis | 0.73449249 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IgG deficiency (HP:0004315) | 3.93181457 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 3.92569587 |
3 | Mitochondrial inheritance (HP:0001427) | 3.73254870 |
4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.53506843 |
5 | Acute encephalopathy (HP:0006846) | 3.46269584 |
6 | Congenital stationary night blindness (HP:0007642) | 3.34769724 |
7 | Increased CSF lactate (HP:0002490) | 3.32477830 |
8 | Progressive macrocephaly (HP:0004481) | 3.31680624 |
9 | Pancreatic cysts (HP:0001737) | 3.30783279 |
10 | Abnormality of alanine metabolism (HP:0010916) | 3.26413797 |
11 | Hyperalaninemia (HP:0003348) | 3.26413797 |
12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.26413797 |
13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.12244366 |
14 | Hepatocellular necrosis (HP:0001404) | 3.06892416 |
15 | Methylmalonic acidemia (HP:0002912) | 3.06495864 |
16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.06368611 |
17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.04914220 |
18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.03910634 |
19 | Abnormality of the renal cortex (HP:0011035) | 2.95730083 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95669060 |
21 | Hepatic necrosis (HP:0002605) | 2.91821826 |
22 | Renal cortical cysts (HP:0000803) | 2.86456395 |
23 | Pancreatic fibrosis (HP:0100732) | 2.82766208 |
24 | Aplastic anemia (HP:0001915) | 2.79935432 |
25 | Severe combined immunodeficiency (HP:0004430) | 2.79133729 |
26 | Attenuation of retinal blood vessels (HP:0007843) | 2.77494988 |
27 | True hermaphroditism (HP:0010459) | 2.76641131 |
28 | Stomatitis (HP:0010280) | 2.73102394 |
29 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.72721328 |
30 | Congenital, generalized hypertrichosis (HP:0004540) | 2.68766959 |
31 | Hypoproteinemia (HP:0003075) | 2.67712204 |
32 | Abolished electroretinogram (ERG) (HP:0000550) | 2.62762596 |
33 | Methylmalonic aciduria (HP:0012120) | 2.59292852 |
34 | Cerebral edema (HP:0002181) | 2.56902545 |
35 | Optic disc pallor (HP:0000543) | 2.50630525 |
36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.47315609 |
37 | Increased serum lactate (HP:0002151) | 2.46197974 |
38 | Abnormality of T cell number (HP:0011839) | 2.42341121 |
39 | Constricted visual fields (HP:0001133) | 2.41854814 |
40 | Renal Fanconi syndrome (HP:0001994) | 2.39991669 |
41 | Abnormality of the prostate (HP:0008775) | 2.39269092 |
42 | Lactic acidosis (HP:0003128) | 2.39252184 |
43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.35180638 |
44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34982992 |
45 | T lymphocytopenia (HP:0005403) | 2.32172028 |
46 | Abnormality of the pons (HP:0007361) | 2.31883806 |
47 | Molar tooth sign on MRI (HP:0002419) | 2.31851420 |
48 | Abnormality of midbrain morphology (HP:0002418) | 2.31851420 |
49 | Abnormality of T cells (HP:0002843) | 2.28138257 |
50 | Prostate neoplasm (HP:0100787) | 2.25925162 |
51 | Thyroiditis (HP:0100646) | 2.24759348 |
52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24676611 |
53 | Increased IgM level (HP:0003496) | 2.22998136 |
54 | Abnormal number of erythroid precursors (HP:0012131) | 2.20680828 |
55 | Hypoplasia of the pons (HP:0012110) | 2.20370759 |
56 | Abnormality of B cell number (HP:0010975) | 2.20021303 |
57 | Pancytopenia (HP:0001876) | 2.19836638 |
58 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.18200908 |
59 | Nephronophthisis (HP:0000090) | 2.16290460 |
60 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.16015951 |
61 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.16015951 |
62 | Decreased central vision (HP:0007663) | 2.14676669 |
63 | Abnormality of serum amino acid levels (HP:0003112) | 2.10732414 |
64 | Type II lissencephaly (HP:0007260) | 2.07042186 |
65 | Absent thumb (HP:0009777) | 2.06760411 |
66 | Exertional dyspnea (HP:0002875) | 2.06696477 |
67 | Type I transferrin isoform profile (HP:0003642) | 2.06348321 |
68 | Lethargy (HP:0001254) | 2.04852123 |
69 | Combined immunodeficiency (HP:0005387) | 2.04344712 |
70 | Abnormality of eosinophils (HP:0001879) | 2.04109522 |
71 | Abnormality of T cell physiology (HP:0011840) | 2.03449100 |
72 | Increased muscle lipid content (HP:0009058) | 2.02997300 |
73 | Pendular nystagmus (HP:0012043) | 2.01473481 |
74 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.00999359 |
75 | Sclerocornea (HP:0000647) | 1.98417689 |
76 | Short tibia (HP:0005736) | 1.97509817 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96363901 |
78 | Dicarboxylic aciduria (HP:0003215) | 1.96363901 |
79 | Polydipsia (HP:0001959) | 1.95949612 |
80 | Abnormal drinking behavior (HP:0030082) | 1.95949612 |
81 | Respiratory failure (HP:0002878) | 1.95827496 |
82 | Abnormality of the renal medulla (HP:0100957) | 1.94369133 |
83 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.94136776 |
84 | Stomach cancer (HP:0012126) | 1.94007808 |
85 | Hypoplasia of the uterus (HP:0000013) | 1.93986636 |
86 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93970713 |
87 | Glycosuria (HP:0003076) | 1.92906546 |
88 | Abnormality of urine glucose concentration (HP:0011016) | 1.92906546 |
89 | Oral leukoplakia (HP:0002745) | 1.92647056 |
90 | Bile duct proliferation (HP:0001408) | 1.92402061 |
91 | Abnormal biliary tract physiology (HP:0012439) | 1.92402061 |
92 | Generalized aminoaciduria (HP:0002909) | 1.90503543 |
93 | Hyperglycinemia (HP:0002154) | 1.85596857 |
94 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.85302973 |
95 | Increased corneal curvature (HP:0100692) | 1.82723119 |
96 | Keratoconus (HP:0000563) | 1.82723119 |
97 | Abnormality of vitamin B metabolism (HP:0004340) | 1.80555175 |
98 | Medial flaring of the eyebrow (HP:0010747) | 1.80394145 |
99 | B lymphocytopenia (HP:0010976) | 1.78974422 |
100 | Panhypogammaglobulinemia (HP:0003139) | 1.78927312 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TLK1 | 4.16436184 |
2 | ZAK | 3.88288986 |
3 | TXK | 3.71735822 |
4 | VRK2 | 3.12140737 |
5 | MAP4K2 | 2.88040580 |
6 | TAOK3 | 2.61151082 |
7 | NUAK1 | 2.50231848 |
8 | BUB1 | 2.47516296 |
9 | VRK1 | 2.32417025 |
10 | KDR | 2.29593104 |
11 | ADRBK2 | 2.27119295 |
12 | TESK2 | 2.12969989 |
13 | BCKDK | 1.99426659 |
14 | MST4 | 1.96393688 |
15 | GRK1 | 1.89593952 |
16 | PASK | 1.84534759 |
17 | FRK | 1.79177107 |
18 | MAP3K12 | 1.70529317 |
19 | CDK19 | 1.62030373 |
20 | STK16 | 1.57751095 |
21 | PINK1 | 1.53043159 |
22 | MUSK | 1.48053224 |
23 | FES | 1.30757200 |
24 | GRK6 | 1.29483229 |
25 | MAP4K1 | 1.25408373 |
26 | WNK3 | 1.24277984 |
27 | ITK | 1.21450184 |
28 | LIMK1 | 1.17096879 |
29 | WNK4 | 1.16543112 |
30 | EIF2AK3 | 1.14897534 |
31 | INSRR | 1.14486908 |
32 | IKBKB | 1.11785270 |
33 | TEC | 1.10431262 |
34 | RPS6KA5 | 1.06929744 |
35 | TRIM28 | 1.05836296 |
36 | SCYL2 | 1.03844157 |
37 | NEK1 | 1.00666215 |
38 | CSNK1G3 | 0.97027302 |
39 | SYK | 0.94736665 |
40 | TIE1 | 0.94269034 |
41 | OXSR1 | 0.93625476 |
42 | NME1 | 0.92624245 |
43 | LMTK2 | 0.91897526 |
44 | IKBKE | 0.90575949 |
45 | KIT | 0.89971905 |
46 | BMPR2 | 0.89543228 |
47 | DAPK1 | 0.88556499 |
48 | ERBB3 | 0.85516819 |
49 | MAP2K2 | 0.83114918 |
50 | CSNK1G2 | 0.78922499 |
51 | MYLK | 0.78059676 |
52 | CAMKK2 | 0.76021558 |
53 | TSSK6 | 0.75860334 |
54 | CSNK1G1 | 0.73271368 |
55 | CSNK1A1L | 0.72439144 |
56 | BMPR1B | 0.70037922 |
57 | EIF2AK2 | 0.68412118 |
58 | PRKCQ | 0.67062328 |
59 | SRPK1 | 0.64788529 |
60 | TAF1 | 0.64604802 |
61 | LCK | 0.63184337 |
62 | PLK3 | 0.62414765 |
63 | PHKG2 | 0.60658379 |
64 | PHKG1 | 0.60658379 |
65 | RPS6KA4 | 0.59489462 |
66 | LYN | 0.59242481 |
67 | DYRK2 | 0.57662867 |
68 | ADRBK1 | 0.54875953 |
69 | MAP2K7 | 0.53724735 |
70 | TRPM7 | 0.53406048 |
71 | BCR | 0.52946278 |
72 | CSF1R | 0.52756997 |
73 | STK39 | 0.52545745 |
74 | BTK | 0.51904100 |
75 | MAPKAPK3 | 0.50949548 |
76 | IGF1R | 0.49384019 |
77 | PLK4 | 0.47860450 |
78 | MAP3K14 | 0.47201560 |
79 | DAPK3 | 0.46456064 |
80 | TESK1 | 0.45462756 |
81 | PIM1 | 0.44128252 |
82 | TBK1 | 0.43976926 |
83 | GRK7 | 0.43584968 |
84 | AURKA | 0.41920300 |
85 | AURKB | 0.40716977 |
86 | FLT3 | 0.38845056 |
87 | PRKCE | 0.38200085 |
88 | GRK5 | 0.36411083 |
89 | PLK1 | 0.36333703 |
90 | CSNK2A1 | 0.36181282 |
91 | ZAP70 | 0.36141285 |
92 | ATR | 0.35811411 |
93 | MAP3K4 | 0.33840493 |
94 | PIK3CG | 0.32757328 |
95 | CDK8 | 0.32395754 |
96 | MKNK1 | 0.31461388 |
97 | MAP2K6 | 0.30883705 |
98 | CSNK1A1 | 0.29782030 |
99 | ACVR1B | 0.29238189 |
100 | PTK2B | 0.28341560 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.04419767 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.27512301 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95305769 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.95032277 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.59357489 |
6 | Asthma_Homo sapiens_hsa05310 | 2.37089360 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.35237907 |
8 | Protein export_Homo sapiens_hsa03060 | 2.31823208 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25817136 |
10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22306395 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20945166 |
12 | RNA polymerase_Homo sapiens_hsa03020 | 2.10312349 |
13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00949209 |
14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.93863787 |
15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86708801 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85292671 |
17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71698231 |
18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63316028 |
19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62002680 |
20 | RNA degradation_Homo sapiens_hsa03018 | 1.61284157 |
21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.60091163 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58553004 |
23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57908542 |
24 | Phototransduction_Homo sapiens_hsa04744 | 1.50309140 |
25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.49820949 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46289581 |
27 | Homologous recombination_Homo sapiens_hsa03440 | 1.46051386 |
28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39844463 |
29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38780567 |
30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33391665 |
31 | Mismatch repair_Homo sapiens_hsa03430 | 1.26947796 |
32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23258549 |
33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23121987 |
34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22846353 |
35 | Spliceosome_Homo sapiens_hsa03040 | 1.22543276 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21878257 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20903228 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17185022 |
39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16159962 |
40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14179956 |
41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13112096 |
42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12154125 |
43 | Peroxisome_Homo sapiens_hsa04146 | 1.10945251 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10342875 |
45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08013909 |
46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06349453 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01427985 |
48 | DNA replication_Homo sapiens_hsa03030 | 0.99331529 |
49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98079481 |
50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97431813 |
51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94419256 |
52 | Base excision repair_Homo sapiens_hsa03410 | 0.92246258 |
53 | Purine metabolism_Homo sapiens_hsa00230 | 0.90795014 |
54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88081130 |
55 | RNA transport_Homo sapiens_hsa03013 | 0.87517855 |
56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83406050 |
57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82989069 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80757984 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78313916 |
60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75031413 |
61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73238831 |
62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73170883 |
63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71563271 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69462976 |
65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69174461 |
66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69015172 |
67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.67825917 |
68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66812562 |
69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66178174 |
70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65987335 |
71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65949969 |
72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65939580 |
73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63700368 |
74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62482233 |
75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59088641 |
76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58664400 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58458933 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56592567 |
79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56076126 |
80 | Alcoholism_Homo sapiens_hsa05034 | 0.53410626 |
81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52712168 |
82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49858480 |
83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49375859 |
84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46284816 |
85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44962160 |
86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41579189 |
87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41544666 |
88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40997995 |
89 | Taste transduction_Homo sapiens_hsa04742 | 0.39297647 |
90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33908887 |
91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32319023 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32015967 |
93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31175801 |
94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31038933 |
95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30405955 |
96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30004035 |
97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27670159 |
98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25937279 |
99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24415161 |
100 | Legionellosis_Homo sapiens_hsa05134 | 0.23344488 |